Wellington Management Group’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Wellington Management Group’s Portfolio OMED Stock Details OMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-14,300	Closed	-$110K	–	2403
2016 Q4	$110K	Hold	14,300	–	–	﹤0.01%	2162
2016 Q3	$163K	Hold	14,300	–	–	﹤0.01%	2151
2016 Q2	$176K	Buy	+14,300	New	+$174K	﹤0.01%	2056
2014 Q2	–	Sell	-50,000	Closed	-$1.68M	–	2334
2014 Q1	$1.68M	Buy	+50,000	New	+$1.69M	﹤0.01%	1727

Other funds holding OMED

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group's OMED Position: Q1 2017 in Review

Wellington Management Group sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q1 2017, closing a stake of 14,300 shares — an estimated $110K sold.

Wellington Management Group first reported a position in OMED in Q1 2014 and held it in 4 quarters. The position peaked at $1.68M in Q1 2014. 85 funds tracked by Wall St. Rank hold OMED as of Q1 2017.

Wellington Management Group reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Wellington Management Group sold 14,300 OncoMed Pharmaceuticals, Inc. shares in Q1 2017, an estimated $110K.
Wellington Management Group first reported a position in OncoMed Pharmaceuticals, Inc. in Q1 2014 and held it in 4 quarters.
Wellington Management Group's OncoMed Pharmaceuticals, Inc. position peaked at $1.68M in Q1 2014.
85 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q1 2017.

Based on Wellington Management Group's 13F filing for Q1 2017, filed 11 May 2017.